ABCG1 and SREBF1 demonstrated hypermethylation, whereas LOXL2, SLC1A5, and TXNIP demonstrated hypomethylation in patients with T2DM compared with healthy controls. This evidence concerns the gene SREBF1 and type 2 diabetes mellitus.